https://biotechmorning.com/news/novartis-avidity-12-billion-bet-lost Biotech Morning en 2026-09-08T14:17:14.894Z Novartis Spent $12 Billion on a Bet. The Bet Just Lost. https://biotechmorning.com/news/sclc-bispecific-immunotherapy-survival-benefit Biotech Morning en 2026-09-08T14:16:26.308Z The Cancer That Barely Flinched at Immunotherapy Just Met Its Match https://biotechmorning.com/news/merck-10-billion-verona-pharma-copd-bet Biotech Morning en 2026-09-08T14:15:41.387Z Merck Just Bet $10 Billion on a COPD Drug. Here's Why. https://biotechmorning.com/news/moderna-2-6-billion-oncology-bet Biotech Morning en 2026-09-08T14:14:55.816Z Moderna Just Bet $2.6 Billion That mRNA Can Kill Cancer https://biotechmorning.com/news/lilly-merida-biosciences-autoimmune-acquisition Biotech Morning en 2026-09-08T14:14:07.623Z Lilly's $2.9B Bet on a Disease Most People Have Never Heard Of https://biotechmorning.com/news/base-editing-sickle-cell-thalassemia-remission Biotech Morning en 2026-09-08T14:13:19.209Z The Gene Editor That Didn't Cut Anything Just Cured Sickle Cell https://biotechmorning.com/news/semaglutide-step-young-children-obesity-results Biotech Morning en 2026-09-08T14:12:29.777Z Novo Nordisk Just Gave Wegovy to Six-Year-Olds. It Worked. https://biotechmorning.com/news/covid-vaccine-xfg-variant-fall-2026 Biotech Morning en 2026-09-07T14:13:24.279Z Your Annual COVID Shot Just Got a New Name You Can't Pronounce https://biotechmorning.com/news/pfizer-seagen-adc-medicus-pharma-deal Biotech Morning en 2026-09-07T14:12:39.604Z Pfizer's $43B Shopping Spree Left Something on the Shelf. Someone Just Picked It Up. https://biotechmorning.com/news/abbvie-etentamig-myeloma-results Biotech Morning en 2026-09-07T14:11:52.774Z AbbVie's Myeloma Drug Just Schooled the Competition https://biotechmorning.com/news/rusfertide-fda-approval-polycythemia-vera Biotech Morning en 2026-09-07T14:11:08.514Z The Injection That Could Replace Your Blood Draws https://biotechmorning.com/news/novo-nordisk-kidney-program-cancelled Biotech Morning en 2026-09-07T14:10:27.923Z Novo Nordisk's $1.3 Billion Kidney Bet Just Went to Zero https://biotechmorning.com/news/novo-nordisk-ziltivekimab-cardiovascular-trials-scrapped Biotech Morning en 2026-09-07T14:09:43.236Z Novo Nordisk's $2.1 Billion Bet on Inflammation Just Went Up in Smoke